Skip to main content

Advertisement

Table 1 General characteristics of the patients with and without LV thrombus formation

From: Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy

Variable No (n=85) Yes (n=15) p-value
Age (years) 57(50,64) 63(50,69) 0.18
Female 15(18%) 1(7%) 0.49
Current smoker 37(44%) 7(47%) 0.20
Hypertension 27(32%) 7(47%) 0.41
Hyperlipidemia 39(46%) 9(60%) 0.47
Diabetes mellitus 6(7%) 2(13%) 0.76
Previous myocardial infarction 4(5%) 0(0%) 0.89
Weight (kg) 84.0(74.5,92.5) 80(77.0,92.0) 0.99
Systolic blood pressure (mmHg) 130(120,144) 135(130,150) 0.33
Peak CK (ugr/L) 2197(1236,4182) 6128(4556,8061) <0.01
Infarct size (% of LAD area by SPECT) 63.8(40.5,76.8) 82.5(71.3,93.1) <0.01
  1. Hypertension is defined as antihypertensive treatment or measured blood pressure above 140/90 mmHg. Hyperlipidemia is defined as baseline fasting total cholesterol above 5.5 mmol/L or previous use of cholesterol lowering medication. P-values refer to differences between the LV thrombus group and those without thrombus formation. CK; creatine kinase, LAD; the left anterior descending artery, SPECT; single photon emission computer tomography.